Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6-Month Double-Blind Placebo-Controlled Trial
Chad Deal(Boston University), John H. Krege(Eli Lilly (United States)), Emmett V. Glass(Eli Lilly (United States)), Erik Fink Eriksen(Eli Lilly (United States)), Jingyuan Wang(Eli Lilly (United States)), Elliott N. Schwartz, P. Cantor(Eli Lilly (United States)), Stephen L. Myers(Eli Lilly (United States)), M. Omizo
Cited by 222
Related Papers
Generation and reproductive phenotypes of mice lacking estrogen receptor β
|Proceedings of the National Academy of Sciences|1998|1.7k
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
|Proceedings of the National Academy of Sciences|1996|903
Genetic control of blood pressure and the angiotensinogen locus.
|Proceedings of the National Academy of Sciences|1995|642